Skip to main content

Table 5 MoCA scores for patients with/without use of antidepressant medication, depression diagnosis from medical history, and by use of strong anticholinergic burden concomitant medication

From: Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)

 

Placebo (n = 411)

Mirabegron Total (n = 425)

Total score at BL, mean (SD)

Total score at EoT, mean (SD)

Change in Total score, mean

Total score at BL, mean (SD)

Total score at EoT, mean (SD)

Change in Total score, mean

Use of antidepressant medicationa

 No (n = 695)

26.9 (2.9)

27.1 (2.8)

0.2

26.9 (2.7)

27.0 (2.7)

0.0

 Yes (n = 141)

26.6 (2.6)

26.9 (2.4)

0.3

26.5 (3.0)

26.6 (2.8)

0.2

Depression diagnosis from medical historyb

 No (n = 683)

26.8 (2.9)

27.0 (2.7)

0.2

27.0 (2.5)

27.0 (2.7)

0.0

 Yes (n = 153)

26.9 (2.6)

27.1 (2.6)

0.1

26.2 (3.3)

26.7 (2.8)

0.4

Use of anticholinergic burden concomitant medicationc

 No (n = 767)

26.8 (2.8)

27.1 (2.7)

0.2

26.8 (2.7)

26.9 (2.7)

0.0

 Yes (n = 69)

26.6 (3.5)

26.6 (3.1)

0

27.0 (2.9)

27.4 (2.4)

0.4

  1. aN = 345 for placebo and 350 for mirabegron total for No, N = 66 for placebo and 75 for mirabegron total for Yes
  2. bN = 341 for placebo and 342 for mirabegron total for No, N = 70 for placebo and 83 for mirabegron total for Yes
  3. cN = 380 for placebo and 387 for mirabegron total for No, N = 31 for placebo and 38 for mirabegron total for Yes